Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
about
Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisStatins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis.Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Precision prevention of oesophageal adenocarcinoma.Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagusStatin use and risk of prostate cancer: Results from the Southern Community Cohort Study.Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillanceProgression of Barrett's esophagus toward esophageal adenocarcinoma: an overviewRole of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.Chemoprevention of gastrointestinal neoplasia.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma.Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma.Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.Ischemic heart disease, factor predisposing to Barrett's adenocarcinoma: A case control studyStatin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.Strategy for prevention of cancers of the esophagus.Esophageal Cancer: Priorities for Prevention
P2860
Q33555216-3150D891-031E-4D95-9117-DED4BFBE4C80Q34324864-637F9B03-E16D-4778-97C8-BC2FFB83B6BDQ34898182-A852510A-39BA-4119-8D7E-A9852FD72A2FQ35046884-A5633A73-E5F7-41D4-B99E-5C9C7D9554BAQ35243217-AAA71299-3A27-4803-B6D0-61B79154EC56Q35778939-C6D223B1-41B7-4469-B9FE-CBE04968E201Q35952232-17E454C4-051E-48AF-AAAC-3C4E5DB4BCD3Q37018314-948CA282-1DEA-4F6E-9FC9-214AD9FC0B6BQ37538933-0CFAE134-94AA-49FD-9A7B-D7FAABD513BBQ37542809-88632B9A-AEDF-4751-9767-4146F0D6C1C0Q37621036-029C2AA6-477D-495E-87E6-C8CD92ED28B1Q38100705-C5CEFA6E-7E4C-4E9D-8424-8E1ADD327810Q38147841-2681E92F-8DAB-4FF3-B085-2F080989789AQ38328606-4E5C66EF-2034-4205-AA35-03F649B1A4FCQ39239195-9182CCBB-A17E-4FEF-9C77-5A5E94E64C5AQ39425042-359F0E14-42F3-4CA7-ABFA-E2D98A12419DQ39530717-F3832BAE-8F44-4268-AE51-5DB0083B5C79Q41610897-834398BC-3A06-4C75-8B72-C6DFF2E33B72Q42791685-74024E54-6CC6-484B-9AD7-A6735FB73184Q43960201-88BFB010-C4D7-4561-9649-C24A7081EB66Q48115635-15A6973B-35F9-47FF-86EB-2082F6FFC44EQ49227522-165371B5-3C1F-41C3-B6FB-1960265220D1Q51048878-2E7662C4-E422-4DF2-B6FD-F3CD7174A89AQ57742481-403E03D3-1FF8-47CC-922E-322DF3082FCD
P2860
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of statin medications and ...... sons with Barrett's esophagus.
@ast
Use of statin medications and ...... sons with Barrett's esophagus.
@en
type
label
Use of statin medications and ...... sons with Barrett's esophagus.
@ast
Use of statin medications and ...... sons with Barrett's esophagus.
@en
prefLabel
Use of statin medications and ...... sons with Barrett's esophagus.
@ast
Use of statin medications and ...... sons with Barrett's esophagus.
@en
P2093
P2860
P1476
Use of statin medications and ...... sons with Barrett's esophagus.
@en
P2093
Brian J Reid
Elizabeth D Kantor
Lynn Onstad
Thomas L Vaughan
P2860
P304
P356
10.1158/1055-9965.EPI-11-1014
P577
2012-01-12T00:00:00Z